AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TRIAMCINOLONE

10 registrations across 5 African markets— 8 active

Markets with TRIAMCINOLONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Triamcinolone Injection_
Injection
🇳🇬NigeriaMalven Medics International Company LtdactiveOct 2029
Fexocalog Injection
Suspension for injection
🇳🇬NigeriaFexona Pharmaceuticals Co LtdactiveAug 2027
NASACORT AQ
Spray nasal / 2% (55 mcg/dose)
🇹🇳TunisiaOPELLA HEALTHCARE UK LTDexpiredJan 2023
KENACORT RETARD 40
Suspension injectable / 40 MG
🇹🇳TunisiaBRISTOL MYERS SQUIBBexpiredJan 1994
Triam
Solution for injection
🇹🇿TanzaniaShin Poong Pharmaceutical Company Limitedactive
Tricort 40
Suspension for injection
🇹🇿TanzaniaCadila Pharmaceuticals Limitedactive
KENACORT RETARD
SUSPENSION INJECTABLE
🇲🇦Moroccoactive
NASOCORT
suspension / 55 mcg / dose
🇸🇳SenegalSANOFI AVENTISactive
KENACORT RETARD
SUSPENSION INJECTABLE
🇲🇦Moroccoactive
NASACORT
SUSPENSION POUR PULVERISATION NASALE
🇲🇦Moroccoactive

TRIAMCINOLONE in Africa — Regulatory Overview

TRIAMCINOLONE is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Nigeria, Tunisia, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.